drugset / Trial / NCT02700815

Capsaicin + Diclofenac Gel in Acute Back Pain or Neck Pain

NCT02700815

Phase 3 Completed 746 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

This randomised, controlled multi-centre parallel group trial will assess the efficacy and tolerability of a topical formulation gel of the combination of diclofenac and capsaicin in comparison to gels with diclofenac alone, capsaicin alone, and placebo for the treatment of acute back pain or neck pain

Timeline

Start
2016-05-09
Primary completion
2017-07-13
Completion
2017-07-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Capsaicin Small molecule 0.075 % Topical
Subject Diclofenac Other / unclassified 2 % Topical

Indications

No indication recorded.